Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 10
2008 7
2009 2
2010 7
2011 5
2012 10
2013 10
2014 8
2015 4
2016 5
2017 6
2018 5
2019 4
2020 2
2021 7
2022 5
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure.
Schmid H. Schmid H. Expert Rev Hematol. 2016 Jan;9(1):5-20. doi: 10.1586/17474086.2016.1112734. Epub 2015 Nov 17. Expert Rev Hematol. 2016. PMID: 26573694 Review.
Since more than two decades erythropoiesis-stimulating agents are the main pillar for treatment of anemia associated with chronic kidney disease. Methoxy polyethylene glycol-epoetin beta (MPG-EPO), also called continuous erythropoietin …
Since more than two decades erythropoiesis-stimulating agents are the main pillar for treatment of anemia associated with chronic kidney dis …
Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease.
Curran MP, McCormack PL. Curran MP, et al. Drugs. 2008;68(8):1139-56. doi: 10.2165/00003495-200868080-00009. Drugs. 2008. PMID: 18484803 Review.
Methoxy polyethylene glycol-epoetin beta (Mircera) is a continuous erythropoietin receptor activator, with a long half-life (approximately 130 hours). ...Methoxy polyethylene glycol-epoetin …
Methoxy polyethylene glycol-epoetin beta (Mircera) is a continuous erythropoietin recept …
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF. Chung EY, et al. Cochrane Database Syst Rev. 2023 Feb 13;2(2):CD010590. doi: 10.1002/14651858.CD010590.pub3. Cochrane Database Syst Rev. 2023. PMID: 36791280 Free PMC article. Review.
OBJECTIVES: To compare the efficacy and safety of ESAs (epoetin alfa, epoetin beta, darbepoetin alfa, methoxy polyethylene glycol-epoetin beta, and biosimilar ESAs against each other, placebo, or no treatment) to treat anaemia in adults with CKD …
OBJECTIVES: To compare the efficacy and safety of ESAs (epoetin alfa, epoetin beta, darbepoetin alfa, methoxy polyethylene …
Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review.
Alsalimy N, Awaisu A. Alsalimy N, et al. Int J Clin Pharm. 2014 Dec;36(6):1115-25. doi: 10.1007/s11096-014-0023-x. Epub 2014 Oct 7. Int J Clin Pharm. 2014. PMID: 25288147 Review.
Different reviews have focused on evaluating the safety and efficacy of methoxy polyethylene glycol-epoetin beta (MPG-EPO), a continuous erythropoietin receptor activator, in CKD patients regardless of dialysis depend …
Different reviews have focused on evaluating the safety and efficacy of methoxy polyethylene glycol-epoetin b …
Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease.
Ohashi N, Sakao Y, Yasuda H, Kato A, Fujigaki Y. Ohashi N, et al. Int J Nephrol Renovasc Dis. 2012;5:53-60. doi: 10.2147/IJNRD.S23447. Epub 2012 Mar 30. Int J Nephrol Renovasc Dis. 2012. PMID: 22536082 Free PMC article.
However, traditional ESAs such as epoetin or darbepoetin have short half-lives and require frequent administration, dose changes, and close monitoring of hemoglobin concentration to maintain target hemoglobin levels. Methoxy polyethylene glycol-epoetin …
However, traditional ESAs such as epoetin or darbepoetin have short half-lives and require frequent administration, dose changes, and close …
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial.
Locatelli F, Hannedouche T, Fishbane S, Morgan Z, Oguey D, White WB. Locatelli F, et al. Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1701-1710. doi: 10.2215/CJN.01380219. Epub 2019 Aug 16. Clin J Am Soc Nephrol. 2019. PMID: 31420350 Free PMC article. Clinical Trial.
RESULTS: In total, 2818 patients underwent randomization, received methoxy polyethylene glycol-epoetin beta or a reference agent, and were followed for a median of 3.4 years (maximum, 8.4 years). ...CONCLUSIONS: In patients with anemia of CKD, o …
RESULTS: In total, 2818 patients underwent randomization, received methoxy polyethylene glycol-epoetin beta …
Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).
Levin NW, Fishbane S, Cañedo FV, Zeig S, Nassar GM, Moran JE, Villa G, Beyer U, Oguey D; MAXIMA study investigators. Levin NW, et al. Lancet. 2007 Oct 20;370(9596):1415-21. doi: 10.1016/S0140-6736(07)61599-2. Lancet. 2007. PMID: 17950856 Clinical Trial.
We aimed to compare the effectiveness of methoxy polyethylene glycol-epoetin beta, given intravenously at 2-week or 4-week intervals, with epoetin treatment one to three times per week for haemoglobin control in haemodialysis patients. ...We did …
We aimed to compare the effectiveness of methoxy polyethylene glycol-epoetin beta, given intravenously at …
Dosing regimen and tolerability of methoxy polyethylene glycol-epoetin beta in Chinese dialysis patients.
Choy BY, Lam MF, Yip T, Tang HL, Wong PN, Chow CC, Yap DY, Chan TM. Choy BY, et al. Nephrology (Carlton). 2013 Aug;18(8):533-8. doi: 10.1111/nep.12105. Nephrology (Carlton). 2013. PMID: 23714233
AIM: To investigate methoxy polyethylene glycol-epoetin beta dosing regimen in treatment naive subjects and dose conversion in darbepoetin alpha treated subjects, in Chinese dialysis patients. ...No significant side-effect was observed. CONCLUSI …
AIM: To investigate methoxy polyethylene glycol-epoetin beta dosing regimen in treatment naive subjects a …
[Switch of methoxy-polyethylene-glycol-epoetin beta to darbepoetin alfa in 263 dialysis patients].
Rieger J, Krummel T, Petitjean P, Chantrel F, Dimitrov Y. Rieger J, et al. Ann Pharm Fr. 2016 Jan;74(1):45-8. doi: 10.1016/j.pharma.2015.06.005. Epub 2015 Jul 17. Ann Pharm Fr. 2016. PMID: 26194063 French.
In early 2012, due to national supply disruption, the methoxy-polyethylene glycol-epoetin beta (CERA) was no longer available and has been replaced by darbepoetin alfa (DA) in all dialysis patients. ...
In early 2012, due to national supply disruption, the methoxy-polyethylene glycol-epoetin beta (CERA) was …
90 results